Novo Foundation company information, Employees & Contact Information

De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells Science | AAAS

Data-driven de novo design of super-adhesive hydrogels Nature

De novo design of porphyrin-containing proteins as efficient and stereoselective catalysts Science | AAAS

De novo designed proteins neutralize lethal snake venom toxins Nature

Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact Gates Foundation

Accurate de novo design of membrane-traversing macrocycles ScienceDirect.com

AlphaDesign: a de novo protein design framework based on AlphaFold | Molecular Systems Biology EMBO Press

MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens MSF Access

Novo Nordisk Foundation enters into strategic framework agreement with the World Health Organization (WHO) to advance global health Novo Nordisk Fonden

De novo and salvage purine synthesis pathways across tissues and tumors ScienceDirect.com

De novo gene synthesis by an antiviral reverse transcriptase Science | AAAS

De novo design of protein structure and function with RFdiffusion Nature

Genetic links between ovarian ageing, cancer risk and de novo mutation rates Nature

Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis Science | AAAS

De novo design of proteins housing excitonically coupled chlorophyll special pairs Nature

Creation of de novo cryptic splicing for ALS and FTD precision medicine Science | AAAS

De novo design of allosterically switchable protein assemblies Nature

De novo design of luciferases using deep learning Nature

De novo design of high-affinity binders of bioactive helical peptides Nature

De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome Nature

Prospective de novo drug design with deep interactome learning Nature

De novo design of protein minibinder agonists of TLR3 Nature

De novo design of miniprotein antagonists of cytokine storm inducers Nature

De novo detection of somatic mutations in high-throughput single-cell profiling data sets Nature

De novo design of protein interactions with learned surface fingerprints Nature

Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides Nature

Deep learning driven de novo drug design based on gastric proton pump structures | Communications Biology Nature

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Science | AAAS

De Novo Postpartum Hypertension: Incidence and Risk Factors at a Safety-Net Hospital American Heart Association Journals

Improving de novo protein binder design with deep learning Nature

De novo development of small cyclic peptides that are orally bioavailable Nature

MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer Nature

De novo design of drug-binding proteins with predictable binding energy and specificity Science | AAAS

A De Novo Metalloenzyme for Cerium Photoredox Catalysis ACS Publications

A de novo paradigm for male infertility Nature

De novo mutations, genetic mosaicism and human disease Frontiers

De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8 Nature

De novo generation of multi-target compounds using deep generative chemistry Nature

De Novo Green Fluorescent Protein Chromophore-Based Probes for Capturing Latent Fingerprints Using a Portable System ACS Publications

De novo design of immunoglobulin-like domains Nature

De novo drug design through artificial intelligence: an introduction Frontiers

Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer Nature

De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 Science | AAAS

Leveraging molecular structure and bioactivity with chemical language models for de novo drug design Nature

De novo design of modular and tunable protein biosensors Nature

GetOrganelle: a fast and versatile toolkit for accurate de novo assembly of organelle genomes Genome Biology

Deep reinforcement learning for de novo drug design Science | AAAS

De novo protein design enables the precise induction of RSV-neutralizing antibodies Science | AAAS

Cardiac Abnormalities in Hispanic/Latina Women With Prior De Novo Hypertensive Disorders of Pregnancy American Heart Association Journals

Combining generative artificial intelligence and on-chip synthesis for de novo drug design Science | AAAS

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report Nature

A defined structural unit enables de novo design of small-molecule–binding proteins Science | AAAS

Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development Nature

Dnmt1 has de novo activity targeted to transposable elements Nature

Efficient hybrid de novo assembly of human genomes with WENGAN Nature

Metabolomics and mass spectrometry imaging reveal channeled de novo purine synthesis in cells Science | AAAS

De novo origins of multicellularity in response to predation - Scientific Reports Nature

Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia | Circulation American Heart Association Journals

De novo generation of hit-like molecules from gene expression signatures using artificial intelligence Nature

Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanisms Nature

LigBuilder V3: A Multi-Target de novo Drug Design Approach Frontiers

Novo Nordisk CEO Lars Sørensen on What Propelled Him to the Top Harvard Business Review

Jennifer Buffett Fast Company

De novo design of catalytic proteins PNAS